Advanced Aseptic Pharmaceutical Production in a Scalable Isolator
April 2023
Scientific paper
About the paper
The paper presents a case study of a scalable, modular isolator system for advanced aseptic pharmaceutical production. It describes how modular isolator and machine components, such as filling, closing, and handling units, can be flexibly combined to support small-batch and high-value drug manufacturing. The article details the system design, including H₂O₂ decontamination, automation with robotics, and integrated in-process control, demonstrating how the platform enables efficient, flexible, and contamination-free production.
Why the topic matters?
The pharmaceutical industry is shifting toward highly specialized, small-batch, and often patient-specific drugs, such as biologics and antibody-drug conjugates. These products require highly flexible, efficient, and contamination-free manufacturing processes. Traditional large-scale systems are often not suitable for these needs. Scalable modular isolator systems address this challenge by enabling rapid changeovers, minimizing product loss, ensuring operator safety, and maintaining strict aseptic conditions, making them essential for modern pharmaceutical production.